slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,391-6,420
Pages 395
Rows per page 30
Slide function
6,391-6,420 of 11,828
30
The slide uses a table to present clinical trial outcomes (PR/CR) and safety data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
05
The slide uses a central white box overlay on a split-image background (food scene and delivery scene).Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit
09
Blue Apron | Investor Presentation Deck | 23 slidesBlue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Business ModelLoop · Mece Breakdown1 hit
10
The slide highlights both year-over-year and quarter-over-quarter margin growth.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit
11
The slide uses a background image of food/wine, likely related to the company's industry.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit
12
The slide uses a background of sliced tomatoes, likely a brand-related visual element for Blue Apron.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Loop · Voice Of Customer1 hit
07
BICR = Blinded Independent Central Review; RANO = Response Assessment in Neuro-Oncology; HGG = High-Grade Glioma; LGG = Low-Grade Glioma; SAEs = Serious Adverse Events.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
09
The slide highlights clinical trial results with specific response and disease control rates for two different RANO criteria.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, though technically a waterfall).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
12
The chart is a classic 'spider plot' used in oncology clinical trials to visualize individual patient tumor burden changes over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
25
Waterfall plot displays individual patient responses; PD indicates Progressive Disease threshold.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
29
Includes a mechanism illustration, a bar chart of H3K27me3 levels, a Kaplan-Meier survival curve, and a dot plot of patient tumor data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
32
The slide uses a central human anatomical illustration to bridge the two distinct types of cancer models presented.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
33
Includes logos for NIH and Pacific Pediatric Neuro-Oncology Consortium.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
35
The chart illustrates dose levels 1-11 with checkmarks indicating completed levels and a clear distinction between weekly and 3-day dosing regimens.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
39
The chart shows a clear dose-response/timing-response relationship where earlier treatment leads to lower viral titers.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
42
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
03
The slide highlights cost efficiency, energy stability, and expansion progress ahead of the Bitcoin halving event.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to present operational KPIs.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
07
The slide uses a split layout: left side for operational cost metrics and right side for growth trajectory.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
08
The slide features a photo of the Odessa facility and a timeline of hash rate growth.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
09
Includes aerial photography of the facility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
10
Includes aerial photography of the mining facility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
11
The slide uses a table structure to bridge historical performance with current run-rate and future acquisition pipeline.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Beat · Financials1 hit
21
The slide uses a waterfall chart for EBITDA growth and a timeline-based logo grid for M&A history.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
11
The slide highlights clinical trial outcomes and regulatory next steps.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes a yellow highlight on the $310 million milestone figure.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
19
The slide highlights a key partnership and associated financial milestones.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
03
The slide uses a 3x2 grid of metrics to demonstrate market dominance and financial health.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit